Use of the SeHCAT test in the investigation of diarrhoea

Postgrad Med J. 1992 Apr;68(798):272-6. doi: 10.1136/pgmj.68.798.272.

Abstract

The SeHCAT test was used to investigate possible bile acid malabsorption in 166 patients presenting to a district general hospital with chronic diarrhoea of uncertain cause. Eighty-four (51%) patients had impaired SeHCAT retention. These included 23 of 28 patients with a possible type I abnormality (terminal ileal resection or disease, previous pelvic radiotherapy), 20 of 74 with a possible type II abnormality (idiopathic diarrhoea), 32 of 45 with a possible type III abnormality (post-cholecystectomy, post-vagotomy), and 9 of 19 with diarrhoea associated with diabetes. Patients with severe bile acid malabsorption demonstrated a good response to cholestyramine whereas the response in patients with a mildly abnormal SeHCAT retention was variable. Bile acid malabsorption is an important cause of diarrhoea in patients presenting with unexplained chronic diarrhoea.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Bile Acids and Salts / metabolism*
  • Cholecystectomy
  • Cholestyramine Resin / therapeutic use
  • Crohn Disease / complications
  • Crohn Disease / metabolism
  • Diagnosis, Differential
  • Female
  • Humans
  • Malabsorption Syndromes / drug therapy
  • Malabsorption Syndromes / etiology*
  • Malabsorption Syndromes / metabolism
  • Male
  • Middle Aged
  • Postoperative Complications / drug therapy
  • Postoperative Complications / etiology
  • Postoperative Complications / metabolism
  • Retrospective Studies
  • Taurocholic Acid / analogs & derivatives*
  • Vagotomy

Substances

  • Bile Acids and Salts
  • Cholestyramine Resin
  • Taurocholic Acid
  • 23-seleno-25-homotaurocholic acid